Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma
Status:
Completed
Trial end date:
2021-06-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and overall response rate
of carfilzomib in combination with dexamethasone for the treatment of multiple myeloma in
China.